The Programme for Global Health and Vaccination Research (GLOBVAC) is extended for the period 2012-2020. The overall aim of the Programme is to support research that can contribute to sustainable improvements in health and health equity for poor people in low- and middle-income countries (LMIC).
The GLOBVAC Programme Board received 4 applications by the 13 February 2013 deadline.
Scientists in India have unveiled a new low-cost vaccine against a deadly virus that kills about half a million children around the world each year.
The conference Implementation Research In Global Health will take place in Bergen 16th and 17th of October 2013.
Please note the upcoming calls for proposals from GLOBVAC Programme.
The GLOBVAC Programme Board received a total of five applications to the support for events call by the 13 February 2013 deadline
Call for applications - Researcher symposia/workshops
All conference participants are invited to organize a symposium as part of the conference programme.
The 8th Conference for Global Health and Vaccination Research and the 25th Anniversary of the Centre for International Health at the University of Bergen will take place in the middle of beautiful Bergen 16-17 October 2013.
Today, a large proportion of people infected with HIV worldwide are offered treatment. Researchers believe that the big challenge ahead will be to achieve effective prevention. Read more about HIV-research in GLOBVAC's new policy brief.
A new call for Innovation Projects for the Industrial Sector has been published under the Programme for Global Health and Vaccination Research – GLOBVAC.
A new call for Support for events has been published under the Programme for Global Health and Vaccination Research – GLOBVAC.
The seminar’s objectives are to inspire new, strong partnerships among research and innovation stakeholders for Global Health in Norway and mobilize new Norwegian actors in the field.